Eupraxia Pharmaceuticals Inc (EPRX) — Capital Reinvestment Ratio

Latest as of March 2020: 0.01x

Eupraxia Pharmaceuticals Inc (EPRX) has a Capital Reinvestment Ratio of 0.01x as of March 2020, meaning it reinvests 0% of its operating cash flow (CA$503.92K) in capital expenditures (CA$3.80K). Check Eupraxia Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x

Capex / Operating Cash Flow

Operating Cash Flow

CA$503.92K

CAD

Capital Expenditures

CA$3.80K

CAD

Data as of

Mar 2020

Most recent filing

Annual Capital Reinvestment Ratio for Eupraxia Pharmaceuticals Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Eupraxia Pharmaceuticals Inc from None to None. See Eupraxia Pharmaceuticals Inc free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow